Suchergebnisse - "Anderten, Helmut"

PubPharm (19)

1

Switching the basal insulin to insulin glargine 300 U/ml in people with type 2 diabetes under basal insulin supported oral therapy : Observational trial on effectiveness and safety

enthalten in: Diabetes, obesity & metabolism | 2022

von Seufert, J. | Wiesli, P. | Fritsche, A. | +4

2

Switching the basal insulin to insulin glargine 300 u/ml in people with type 2 diabetes under basal insulin supported oral therapy – observational trial on effectiveness and safety

sonderdruck aus: Diabetes, obesity and metabolism | 2022

von Seufert, J. | Wiesli, P. | Fritsche, A. | +4

3

Switching the basal insulin to insulin glargine 300 U/ ml in people with type 2 diabetes under basal insulin supported oral therapy : Observational trial on effectiveness and safety

enthalten in: Diabetes, Obesity and Metabolism | 2022

von Seufert, J. | Wiesli, P. | Fritsche, A. | +4

4

Preulcerous Risk Situation in Diabetic Foot Syndrome : Proposal for a Simple Ulcer Prevention Score

enthalten in: Journal of diabetes science and technology | 2021

von Kress, S. | Anderten, H. | Borck, A. | +9

5

Effectiveness and safety of insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes after failure of oral therapy in a real-world setting

enthalten in: Diabetes, obesity & metabolism | 2020

von Pfohl, M. | Jornayvaz, F. | Fritsche, A. | +4

6

Effectiveness and safety of insulin glargine 300 U/mL in insulin‐naïve patients with type 2 diabetes after failure of oral therapy in a real‐world setting

sonderdruck aus: Diabetes, obesity and metabolism | 2020

von Pfohl, M. | Jornayvaz, F. | Fritsche, A. | +4

7

Titration of insulin glargine 100 U/mL when added to oral antidiabetic drugs in patients with type 2 diabetes : results of the TOP-1 real-world study

enthalten in: Acta diabetologica | 2020

von Pscherer, S. | Anderten, H. | Pfohl, M. | +5

8

Effectiveness and safety of insulin glargine 300 U/mL in insulin‐naïve patients with type 2 diabetes after failure of oral therapy in a real‐world setting

enthalten in: Diabetes, Obesity and Metabolism | 2020

von Pfohl, M. | Jornayvaz, F. | Fritsche, A. | +4

9

Predictors of treatment response in type-2 diabetes patients initiating basal-supported oral therapy with insulin glargine 100 U/mL : A sub-analysis of the Titration and OPtimisation (TOP) registry

enthalten in: Diabetes, obesity & metabolism | 2019

von Pfohl, M. | Pscherer, S. | Fritsche, A. | +5

10

Titration of insulin glargine 100 U/mL when added to oral antidiabetic drugs in patients with type 2 diabetes: results of the TOP-1 real-world study

enthalten in: Acta diabetologica | 2019

von Pscherer, S. | Anderten, H. | Pfohl, M. | +5